Neurodegenerative disease researchers in the U.K. fear the Brexit will curtail their access to EU funds and complicate international collaborations. Analysts agree that a U.K. exit is likely to harm big science across the continent.
11-Jul-2016 12:05 PM EDT Add to Favorites
Researchers are making progress in understanding exactly how sleep helps the brain lay down memories and remove waste products. The findings may have implications for diseases in which sleep and memory are impaired. Alzforum reports.
23-May-2016 5:05 PM EDT Add to Favorites
Drug Trials in Frontotemporal Dementia: Can Industry, Academia, Families and Regulators Get on One Page?
In Washington, D.C., stakeholders in frontotemporal dementia came together to apply lessons learned from setbacks of Alzheimer’s drug development to the emerging field of therapy evaluation in FTD.
26-Apr-2016 1:05 PM EDT Add to Favorites
Last month, scientists gathered to powwow about where we are with FTD, DLB, and cerebrovascular disorders and how best to target research dollars to them. Researchers articulated funding priorities for each of these diseases, which will inform the...
21-Apr-2016 1:05 PM EDT Add to Favorites
A free, open online course on rare forms of dementia aims to spread knowledge while harnessing social learning.
18-Feb-2016 4:05 PM EST Add to Favorites
Studies report no reduction in the amyloid-β peptide or the plaques it forms. Hints of efficacy came from four people free of the ApoE4 risk gene for AD, and one patient who was on it for nearly two years. Meanwhile, scientists uncovered a new...
15-Feb-2016 11:05 AM EST Add to Favorites
Inhibiting the Rho kinases ROCK1 and ROCK2 with fasudil, a drug approved in China and Japan, stimulates tau autophagy in cell culture and flies.
9-Feb-2016 11:05 AM EST Add to Favorites
While regulators are trying to figure out what went wrong, independent chemists have dug into the mechanism of what may have been a "dirty" drug.
1-Feb-2016 10:05 AM EST Add to Favorites